Myocardial Iron Deficiency and Mitochondrial Dysfunction in Advanced Heart Failure in Humans

Area of Science:

• Cardiology
• Biochemistry
• Medical Imaging

Background:

• Myocardial iron deficiency (MID) in heart failure (HF) is understudied.
• Understanding MID's role and non-invasive monitoring is crucial for HF management.

Purpose of the Study:

• Define criteria for MID in human hearts.
• Investigate the pathophysiological impact of MID in HF.
• Assess non-invasive monitoring of MID using cardiac MRI.

Main Methods:

• Measured biventricular iron levels in explanted human hearts (HF vs. non-failing controls).
• Assessed myocardial remodeling, mitochondrial function, and oxidative stress.
• Utilized cardiac magnetic resonance imaging (T2*) for iron quantification.

Main Results:

• Identified 23% of HF patients with MID (HF-MID), associated with higher NYHA class and poorer LV function.
• HF-MID hearts showed suppressed mitochondrial activity and impaired oxidative stress defenses.
• Cardiac MRI T2* effectively correlated with myocardial iron levels.

Conclusions:

• MID is prevalent in advanced HF, exacerbating cardiac remodeling via mitochondrial dysfunction and oxidative stress.
• Cardiac MRI offers a potential non-invasive method for monitoring MID in HF.